Page last updated: 2024-11-04

fluoroacetic acid and Disease Models, Animal

fluoroacetic acid has been researched along with Disease Models, Animal in 4 studies

fluoroacetic acid: N1 same as NM; RN given refers to parent cpd
fluoroacetic acid : A haloacetic acid that is acetic acid in which one of the methyl hydrogens is substituted by fluorine.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"The decrease of cyclic GMP (cGMP) level in the brain, contributing to cognitive and memory deficit in hyperammonemia (HA), has been attributed to the interference of ammonia with the NMDA/nitric oxide/soluble guanylate cyclase (GC)/cGMP pathway in neurons."7.74Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices. ( Albrecht, J; Felipo, V; Fresko, I; Konopacka, A; Zielińska, M, 2007)
"The decrease of cyclic GMP (cGMP) level in the brain, contributing to cognitive and memory deficit in hyperammonemia (HA), has been attributed to the interference of ammonia with the NMDA/nitric oxide/soluble guanylate cyclase (GC)/cGMP pathway in neurons."3.74Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices. ( Albrecht, J; Felipo, V; Fresko, I; Konopacka, A; Zielińska, M, 2007)
"17), whereas [(18)F]FAc has the highest bioavailability (area under concentration of radiotracer vs."1.35Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model. ( Chang, CH; Chang, CW; Chang, TJ; Chou, TK; Lin, WJ; Liu, RS; Wang, HE; Wang, SJ; Wu, CY, 2009)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, H1
Tang, G1
Hu, K1
Huang, T1
Liang, X1
Wu, Z1
Li, S1
Liu, RS1
Chou, TK1
Chang, CH1
Wu, CY1
Chang, CW1
Chang, TJ1
Wang, SJ1
Lin, WJ1
Wang, HE1
Lo, FS1
Zhao, S1
Erzurumlu, RS1
Zielińska, M1
Fresko, I1
Konopacka, A1
Felipo, V1
Albrecht, J1

Other Studies

4 other studies available for fluoroacetic acid and Disease Models, Animal

ArticleYear
Comparison of three ¹⁸F-labeled carboxylic acids with ¹⁸F-FDG of the differentiation tumor from inflammation in model mice.
    BMC medical imaging, 2016, Jan-12, Volume: 16

    Topics: Animals; Benzoates; Carboxylic Acids; Diagnosis, Differential; Disease Models, Animal; Fluoroacetate

2016
Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:3

    Topics: Animals; Autoradiography; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluoroa

2009
Astrocytes promote peripheral nerve injury-induced reactive synaptogenesis in the neonatal CNS.
    Journal of neurophysiology, 2011, Volume: 106, Issue:6

    Topics: Age Factors; Aldehyde Dehydrogenase 1 Family; Amines; Animals; Animals, Newborn; Astrocytes; Biophys

2011
Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
    Neurotoxicology, 2007, Volume: 28, Issue:6

    Topics: Acetates; Aconitate Hydratase; Animals; Astrocytes; Cerebral Cortex; Cyclic GMP; Disease Models, Ani

2007